bethanechol has been researched along with Myotonic Dystrophy in 1 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bethanechol resolved the gastrointestinal symptoms and allowed increase of daily feeding volume." | 5.34 | [Bethanechol for neonatal transient gastrointestinal dismotility in two cases of congenital myotonic dystrophy]. ( Matsui, K; Shibasaki, J; Watanabe, T; Yamashita, S, 2007) |
| "Treatment with bethanechol resolved the gastrointestinal symptoms and allowed increase of daily feeding volume." | 1.34 | [Bethanechol for neonatal transient gastrointestinal dismotility in two cases of congenital myotonic dystrophy]. ( Matsui, K; Shibasaki, J; Watanabe, T; Yamashita, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsui, K | 1 |
| Yamashita, S | 1 |
| Shibasaki, J | 1 |
| Watanabe, T | 1 |
1 other study available for bethanechol and Myotonic Dystrophy
| Article | Year |
|---|---|
[Bethanechol for neonatal transient gastrointestinal dismotility in two cases of congenital myotonic dystrophy].
Topics: Bethanechol; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Infant, Newborn; Muscarin | 2007 |